Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 36 of 58, showing 10 Applications out of 576 total, starting on record 351, ending on 360

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

351.

ECCT/20/03/01   GlycoShig3
    A Phase 2a age descending study to investigate the safety and immunogenicity of the SF2a-TT15 synthetic carbohydrate-based conjugate vaccine against Shigella flexneri 2a in adult, children and infant target population in endemic countries.   
Principal Investigator(s)
1. Fredrick Kipyegon Sawe
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Kericho
 
23-05-2020 View

352.

ECCT/20/02/03   LNG 1.5mg for pericoital use
    A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg    
Principal Investigator(s)
1. Anne Mwihaki Macharia
Site(s) in Kenya
1. Nairobi County (Nairobi City county)
2. Kiambu County (Kiambu county)
 
13-05-2020 View

353.

ECCT/19/12/02   VPM1002 Phase III PoI
    A multicenter, Phase III double blind, randomized active controlled study to evaluate efficacy and safety of VPM1002 in comparison with BCG in prevention of Mycobacterium tuberculosis infection in newborn infants.     
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI-CRDR Nairobi (Nairobi City county)
2. KEMRI-CRDR Siaya (Siaya county)
 
20-04-2020 View

354.

ECCT/19/11/05   Point-of-care Urine Monitoring of Adherence (PUMA)
    Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP   Pilot trial to examine the feasibility, acceptability and impact on longer-term adherence of an intervention using a new urine-based tenofovir adherence assay       
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
15-04-2020 View

355.

ECCT/19/11/03   A Pilot BE study for Enalpril 5mg
    A bioequivalent pilot study of a locally-produced brand of enalapril tablets:  a key step towards implementation of bioequivalent study regulatory requirements in East Africa   
Principal Investigator(s)
1. Simon Njoroge Njenga
Site(s) in Kenya
Kenya Medical Research Institute
 
09-04-2020 View

356.

ECCT/19/10/03   Smoking Cessation Study for PLHIV
    Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya   
Principal Investigator(s)
1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch
Site(s) in Kenya
Mathari National Teaching and Referral Hospital
 
03-04-2020 View

357.

ECCT/19/10/02   AMC-100
    A Phase II Multicenter Study of Pomalidomide Monotherapy in HIV-Positive Individuals with Kaposi Sarcoma (KS) in Sub-Saharan Africa (SSA)   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
01-04-2020 View

358.

ECCT/19/10/01   AMC-099
    A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)   
Principal Investigator(s)
1. ELKANAH ORANGO OMENGE
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
01-04-2020 View

359.

ECCT/19/12/01   BOHEMIA PK400
    Mosquitocidal effect and pharmacokinetics of different ivermectin dose regimens in preparation for BOHEMIA cluster randomized controlled trial.   
Principal Investigator(s)
1. Marta Ferreira Maia
Site(s) in Kenya
Kilifi
 
01-04-2020 View

360.

ECCT/20/01/01   LEVERAGING THE DEPRESSION AND PRIMARY-CARE PARTNERSHIP FOR EFFECTIVENESS-IMPLEMENTATION RESEARCH
    A SEQUENTIAL, MULTIPLE ASSIGNMENT RANDOMIZED TRIAL (SMART) FOR NON-SPECIALIST TREATMENT OF COMMON MENTAL DISORDERS IN KENYA: LEVERAGING THE DEPRESSION AND PRIMARY-CARE PARTNERSHIP FOR EFFECTIVENESS-IMPLEMENTATION RESEARCH (DAPPER) PROJECT (SMART-DAPPER)           
Principal Investigator(s)
1. Anne Muthoni Mathai
2. Susan Meffert
Site(s) in Kenya
Kisumu County Hospital
 
31-03-2020 View